The ad goes on to tout Hims & Hers' weight loss drugs as less expensive alternatives to medications like Ozempic and Wegovy, ...

The Trump administration has promised that addressing childhood obesity will be a key part of its “Make America Healthy Again ...

Nichola Hawes is on trial for alleged fraud and selling or supplying medicines without proper prescriptions.

A study finds GLP-1 weight-loss drugs may pose vision risks, revealing an unexpected medical irony. A paradoxical insight: ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

The ad from the telehealth company Hims & Hers promoted the company’s compounded weight loss drugs. The ad portrayed the ...

The next FDA Commissioner could solve two big problems with one powerful policy: encourage independent testing of both ...

From revenue to R&D investment, Novo and Lilly and their mega-blockbuster weight loss drugs Zepbound and Wegovy have moved ...

Experts from five states have sounded the alarm about blockbuster weight loss drugs like Ozempic leaving users blind, ...

These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause ...